BiomX PHGE Stock
BiomX Price Chart
BiomX PHGE Financial and Trading Overview
| BiomX stock price | 0.27 USD |
| Previous Close | 0.52 USD |
| Open | 0.51 USD |
| Bid | 0.53 USD x 400 |
| Ask | 0.54 USD x 100 |
| Day's Range | 0.51 - 0.56 USD |
| 52 Week Range | 0.34 - 1.62 USD |
| Volume | 443.3K USD |
| Avg. Volume | 5.11M USD |
| Market Cap | 14.36M USD |
| Beta (5Y Monthly) | 1.429 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.95 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.5 USD |
PHGE Valuation Measures
| Enterprise Value | 27.77M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 28.47895 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.833 |
Trading Information
BiomX Stock Price History
| Beta (5Y Monthly) | 1.429 |
| 52-Week Change | -61.76% |
| S&P500 52-Week Change | 14.81% |
| 52 Week High | 1.62 USD |
| 52 Week Low | 0.34 USD |
| 50-Day Moving Average | 0.46 USD |
| 200-Day Moving Average | 0.6 USD |
PHGE Share Statistics
| Avg. Volume (3 month) | 5.11M USD |
| Avg. Daily Volume (10-Days) | 2.75M USD |
| Shares Outstanding | 26.53M |
| Float | 18.01M |
| Short Ratio | 0.12 |
| % Held by Insiders | 18.82% |
| % Held by Institutions | 44.51% |
| Shares Short | 326.5K |
| Short % of Float | 1.25% |
| Short % of Shares Outstanding | 1.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.13% |
| Return on Equity (ttm) | -79.71% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -33333000 USD |
| Net Income Avi to Common (ttm) | -18567000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.05M USD |
| Total Cash Per Share (mrq) | 0.53 USD |
| Total Debt (mrq) | 9.38M USD |
| Total Debt/Equity (mrq) | 48.94 USD |
| Current Ratio (mrq) | 2.656 |
| Book Value Per Share (mrq) | 0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29207000 USD |
| Levered Free Cash Flow (ttm) | -17589000 USD |
Profile of BiomX
| Country | United States |
| State | N/A |
| City | Ness Ziona |
| Address | 22 Einstein Street |
| ZIP | 7414003 |
| Phone | 972 7 2394 2377 |
| Website | https://www.biomx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 52 |
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. The company was founded in 2015 and is headquartered in Ness Ziona, Israel.
Q&A For BiomX Stock
What is a current PHGE stock price?
BiomX PHGE stock price today per share is 0.27 USD.
How to purchase BiomX stock?
You can buy PHGE shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BiomX?
The stock symbol or ticker of BiomX is PHGE.
Which industry does the BiomX company belong to?
The BiomX industry is Biotechnology.
How many shares does BiomX have in circulation?
The max supply of BiomX shares is 29.01M.
What is BiomX Price to Earnings Ratio (PE Ratio)?
BiomX PE Ratio is now.
What was BiomX earnings per share over the trailing 12 months (TTM)?
BiomX EPS is -1.95 USD over the trailing 12 months.
Which sector does the BiomX company belong to?
The BiomX sector is Healthcare.